FIELD: medicine, pharmaceutics.
SUBSTANCE: microparticle contains an agglomerate of particles containing a hydrophilic active substance, wherein the particle contains an amphiphilic polymer composed of a hydrophobic segment of polyhydroxy acid and a hydrophilic segment of polysaccharide or polyethylene glycol, and a hydrophilic active substance. What is also disclosed is a method of producing the agglomerated microparticles, which involves (a) a stage of preparing a reverse phase emulsion, (b) a stage of preparing a solid residue containing the hydrophilic active substance, and (c) a stage of introducing the solid residue into a liquid phase containing a surface modifier.
EFFECT: agglomerated microparticles provide the effective encapsulation of the hydrophilic active substance and the release of the hydrophilic active substance at an appropriate speed.
14 cl, 22 dwg, 4 tbl, 31 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOGENIC COMPOSITION | 2011 |
|
RU2593789C2 |
SUNITINIB-BASED COMPOSITIONS AND METHODS FOR USING THEM FOR TREATING EYE DISEASES | 2015 |
|
RU2729731C2 |
BIODEGRADABLE, SEMI-CRYSTALLINE, PHASE SEPARATED, THERMOPLASTIC MULTI-BLOCK COPOLYMERS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2012 |
|
RU2662818C2 |
IMPROVING ABSORPTION OF THERAPEUTIC AGENTS THROUGH MUCOUS MEMBRANES OR SKIN | 2009 |
|
RU2519193C2 |
PHARMACEUTICAL COMPOSITIONS OF GOSERELIN MICROSPHERES WITH PROLONGED RELEASE | 2014 |
|
RU2694901C2 |
PHARMACEUTICAL DEPOT, CONTAINING N-{ 5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL} -3-FLUORO-4-([PYRIDIN-2-YLMETHOXY)BENZAMIDE | 2009 |
|
RU2538702C2 |
HIGH STABILITY PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2427383C2 |
PREPARATION OF POLYLACTIDE-POLYGLYCOLIDE MICROPARTICLES CHARACTERISED BY SIGMOIDAL RELEASE PROFILE | 2014 |
|
RU2658004C2 |
METHOD OF PRODUCTION, USE AND COMPOSITION OF MINOR SPHERICAL PARTICLES PRODUCED IN CONTROLLED PHASE SEPARATION | 2004 |
|
RU2426590C2 |
IMMUNOSTIMULANT | 2014 |
|
RU2702987C2 |
Authors
Dates
2013-08-20—Published
2009-02-20—Filed